Long-term weight loss and metabolic benefit from Roux-en-Y gastric bypass in patients with superobesity.

Styliani MantziariTheodoros ThomopoulosFrancesco AbborettiSergio Gaspar-FigueiredoAnna DayerNicolas DemartinesMichel Suter

Published in: BJS open (2022)

Substantial improvement in co-morbidities was observed in all patients 10 years after RYGB. Total weight loss was similar in SO and MO patients, leaving SO patients with higher BMI. Suboptimal TBWL 5 years after surgery in SO, especially female patients, may warrant prompt reassessment to improve long-term outcomes.

Keyphrases

weight loss
roux en y gastric bypass
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
body mass index
type diabetes
gastric bypass
physical activity
weight gain
obese patients